Skip to main content
OpenTrials

Clinical trial condition

Bone Diseases, Endocrine

Explore clinical trials studying Bone Diseases, Endocrine. Study availability and eligibility vary by location and protocol.

350 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Bone Diseases, Endocrine trial results

Completed

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

NCT01706783

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site København Ø, Denmark
  • Novo Nordisk Investigational Site Odense, Denmark
  • Novo Nordisk Investigational Site Stockholm, Sweden
View Trial Details
Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

NCT00446082

Conditions
Acromegaly, Adenocarcinoma, Bone Diseases, +18 more
Locations
  • Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States
  • University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
View all 17 locations
View Trial Details
Completed

Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

NCT02229851

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 117 locations
View Trial Details
Completed

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

NCT03075644

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Chiba-shi, Chiba, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Kagoshima, Japan
View Trial Details
Completed

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

NCT00447499

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Diabetes and Endocrine Associates La Mesa, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Denver VA Medical Center Denver, Colorado, United States
  • Northwestern University The Feinberg School of Medicine Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions